Tofacitinib – the fi rst JAK inhibitor in the treatment of ulcerative colitis. Beginning of the therapeutic era of „small molecules“ in infl ammatory bowel disease?
Authors:
Lukáš M.
Authors place of work:
Klinické a výzkumné centrum pro střevní záněty ISCARE I. V. F. a. s. a 1. LF UK, Praha
Published in the journal:
Gastroent Hepatol 2019; 73(4): 363-365
Category:
doi:
https://doi.org/10.14735/amgh2019363
Zdroje
1. Vaníčková R, Lukáš M. „Malé molekuly“ v léčbě idiopatických střevních zánětů. Farmakoterapeutická revue 2018; 4.
2. Cramer JA, Roy A, Burrell A et al. Medication compliance and persistence: terminology and definitions. Value Heal 2008; 11 (1): 44–47. doi: 10.1111/j.1524-4733.2007.00213.x.
3. Šenolt L. Inhibice Janus kinázy v léčbě revmatoidní artritidy. Farmakoterapie 2011 (3): 283–289.
4. Sandborn WJ, Ghosh S, Panes J et al. Tofacitinib, an oral janus kinase inhibitor, in active ulcerative colitis. N Engl J Med 2012; 367 (7): 616–624. doi: 10.1056/NEJMoa1112168.
5. Sandborn WJ, Su C, Sands BE et al. Tofacitinib as induction and maintenance therapy for ulcerative colitis. N Engl J Med 2017; 376 (18): 1723–1736. doi: 10.1056/NEJMoa1606910.
6. Rubin DT, Dubinski M, Lukas M et al. Long-term efficacy of tofacitinib in patients who received extended induction therapy: results from OCTAVE open study for tofacitinib delayed responders. J Crohns Colitis 2019; 13 (Suppl 1): S050–S052. doi: 10.1093/ecco-jcc/jjy222.077.
7. European Medicines Agency. Restrictions in use of Xeljanz while EMA reviews risk of blood clots in lungs. 2019. [online]. Available from: https: //www.ema.europa.eu/en/news/restrictions-use-xeljanz-while-ema-reviews-risk-blood-clots-lungs.
Štítky
Paediatric gastroenterology Gastroenterology and hepatology SurgeryČlánok vyšiel v časopise
Gastroenterology and Hepatology
2019 Číslo 4
- Spasmolytic Effect of Metamizole
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Metamizole in perioperative treatment in children under 14 years – results of a questionnaire survey from practice
- Current Insights into the Antispasmodic and Analgesic Effects of Metamizole on the Gastrointestinal Tract
- Obstacle Called Vasospasm: Which Solution Is Most Effective in Microsurgery and How to Pharmacologically Assist It?
Najčítanejšie v tomto čísle
- Insulinoma as a cause of severe hypoglycemia in a patient with neurological symptoms
- Part 4 – Mortality and life expectancy in IBD patients
- Dysphagia as a symptom of an adverse effect of anticoagulant therapy
- New oral anticoagulants and upper gastrointestinal bleeding